Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance

BACKGROUND: Prolonged (val)ganciclovir [(V)GCV] exposure for ≥6 weeks is a known predisposing factor for cytomegalovirus (CMV) drug resistance. However, the selection of this threshold was based on limited data. In this study, we sought to reappraise the risk factors for the development of (V)GCV re...

Descripción completa

Detalles Bibliográficos
Autores principales: Acquier, M, Taton, B, Alain, S, Garrigue, I, Mary, J, Pfirmann, P, Visentin, J, Hantz, S, Merville, P, Kaminski, H, Couzi, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933945/
https://www.ncbi.nlm.nih.gov/pubmed/36817745
http://dx.doi.org/10.1093/ofid/ofad018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933945/
https://www.ncbi.nlm.nih.gov/pubmed/36817745
http://dx.doi.org/10.1093/ofid/ofad018

Ejemplares similares